Navigation Links
Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
Date:3/18/2013

esired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2012, and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or t
'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... research analysis approaches are evolving across industry sectors ... are now examining better ways to engage with ... how consumers inform themselves and make critical purchasing ... by benchmarking firm, Best Practices, LLC, one area ...
(Date:7/11/2014)... Research and Markets has announced ... X-ray Film Industry Report 2014" report to their ... Global And Chinese Medical X-Ray Film Industry Report ... current state of the Global medical X-ray film industry ... report provides a basic overview of the industry including ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global and Chinese Medical X-ray Film Industry Report 2014 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... BioTrends Research Group, Inc. recently published its ... is based on online survey ... radiologists and interventional nephrologists). It provides an in-depth view ... patterns related to both vascular access placement and maintenance. ...
... Aug. 24 Sunridge International (OTC Bulletin Board: ... next month to have meetings with key brokers and funds. ... to our company,s technology, and to facilitate funding for Sunridge ... "Now is a good time for this project," states G. ...
Cached Medicine Technology:Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market 2
(Date:7/14/2014)... Botanica Day Spa announced last month that their ... the day spa in down town Clearwater, FL on ... refreshments will be served as clients are invited to ... and great deals on spa services, including the ... (also known as “facial shaving”) is a simple and ...
(Date:7/14/2014)... 2014 (HealthDay News) -- Eye tests could be used ... disease, two new studies suggest. In one study, ... eye test found a significant association between levels of ... levels of the plaques in the brain. Beta-amyloid plaques ... This type of eye test could be used in ...
(Date:7/14/2014)... News) -- Stress can slow a woman,s metabolism and lead ... 58 women, average age 53, who were asked about their ... than included 930 calories and 60 grams of fat. The ... women to burn off those calories and fat. On ... the previous 24 hours burned 104 fewer calories in the ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... Ultra performance liquid chromatography or UPLC is ... of liquid chromatography that involves the use ... conditions to separate chromatographic compounds. This highly ... faster detection and analysis of chromatography samples. ...
(Date:7/14/2014)... Atlanta, GA (PRWEB) July 14, 2014 ... networking and relationship-marketing firm, announced today that nominations ... for the 2014 Information Security Executive® (ISE®) North ... Security Executive® of the Year, which recognizes executives ... organizations through risk management, data-asset protection, regulatory compliance, ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3Health News:Eye Tests Might Help ID Alzheimer's, Studies Suggest 2Health News:Stress May Leave You Heading to the Cookie Jar 2Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3
... Teriparatide may help asthma patients avoid fracture, researchers ... A new drug has proven superior to standard ... treatment, researchers say. , Glucocorticoid medicines such as ... disorders, skin allergies and other conditions, researchers note. ...
... suspect it may cause airway inflammation, , , WEDNESDAY, Nov. 14 ... to help protect the airways now appears to be a ... a role in the development of asthma, according to new ... New England Journal of Medicine , Yale University researchers ...
... Researchers at the Medical College of Wisconsin in Milwaukee ... normal tissue after exposure may be reduced by a ... in the on line issue of the International Journal ... that long-term administration of the drug captopril, starting at ...
... data on worldwide cancer incidence, researchers at the Moores ... have shown a clear association between deficiency in exposure ... , UVB exposure triggers photosynthesis of vitamin D3 ... also available through diet and supplements. Previous studies from ...
... scientists say , , WEDNESDAY, Nov. 14 (HealthDay News) -- ... Alzheimer,s diagnosis than white patients, a new study suggests. ... Indian descent diagnosed with the disease were found to ... patients, patients of Hispanic or black ethnicity were ...
... 14 Biodel Inc. (Nasdaq:,BIOD) today announced that ... Financial Officer, Vice President of Corporate Development,and Treasurer, ... to welcome Gerard to our team," said Dr. ... in executing,complex financial transactions and negotiating marketing partnerships ...
Cached Medicine News:Health News:New Drug Fights Medication-Linked Bone Loss 2Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients 2Health News:Global view shows link between endometrial cancer and vitamin D status 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 3Health News:Blacks, Hispanics Live Longer With Alzheimer's 4Health News:Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer 2Health News:Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer 3
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... are used by hospitals, clinics and the ... health conditions. The majority of these products ... are offered in strip, cassette, and stick ... membrane tests are also available. All require ...
... The CALBIOTECH INC. (CBI) Prolactin ELISA ... of prolactin in human serum or plasma. ... chain polypeptide hormone with a molecular weight ... is based on a solid phase direct ...
... is a polypeptide hormone secreted in significant ... the placenta. Prolactin, in synergy with estrogen, ... initiation and maintenance of mammary gland growth ... prolactin may have effects on cell growth ...
Medicine Products: